🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 7 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/12/2019 73,33 73,63 61,85 63,33 -13,26% 16,06% 6.140.200
29/11/2019 69,25 73,72 67,81 73,01 +5,78% 8,53% 2.054.500
27/11/2019 67,00 70,28 64,50 69,02 +1,95% 8,63% 3.542.800
26/11/2019 58,94 67,77 58,50 67,70 +18,79% 15,73% 6.185.300
25/11/2019 53,19 59,72 52,58 56,99 +15,83% 13,42% 5.387.600
22/11/2019 49,39 49,77 47,90 49,20 +0,29% 3,79% 964.300
21/11/2019 48,90 49,75 48,40 49,06 +1,47% 2,76% 1.404.900
20/11/2019 50,00 50,37 46,93 48,35 -4,26% 6,88% 3.451.100
19/11/2019 49,29 51,84 48,89 50,50 +4,84% 5,98% 2.148.800
18/11/2019 48,29 48,99 46,67 48,17 +1,54% 4,80% 1.633.000
15/11/2019 47,00 47,84 45,22 47,44 -2,19% 5,57% 2.375.700
14/11/2019 48,48 49,78 46,43 48,50 -0,02% 6,91% 2.073.700
13/11/2019 45,41 48,87 44,44 48,51 +7,15% 9,76% 2.640.200
12/11/2019 43,23 45,85 42,91 45,28 +5,44% 6,81% 1.896.600
11/11/2019 41,72 43,41 41,12 42,94 +2,00% 5,49% 1.044.000
08/11/2019 40,00 42,12 39,32 42,10 +6,31% 7,00% 1.165.500
07/11/2019 39,63 40,16 38,88 39,60 +0,97% 3,23% 877.500
06/11/2019 39,87 40,28 39,06 39,22 -1,28% 3,06% 893.800
05/11/2019 39,44 39,82 38,84 39,73 +0,68% 2,48% 961.300
04/11/2019 41,75 42,29 38,65 39,46 -4,87% 8,72% 1.848.300
01/11/2019 40,29 41,64 39,94 41,48 +3,57% 4,22% 1.511.800
31/10/2019 40,04 40,65 39,60 40,05 +0,05% 2,62% 1.161.100
30/10/2019 39,85 40,35 38,85 40,03 +0,33% 3,76% 857.600
29/10/2019 39,35 40,30 39,00 39,90 +1,63% 3,29% 1.089.900
28/10/2019 38,81 39,49 38,28 39,26 +1,84% 3,11% 958.100
25/10/2019 36,90 39,41 36,90 38,55 +4,56% 6,80% 1.427.900
24/10/2019 38,81 38,87 36,38 36,87 -7,01% 6,42% 2.169.500
23/10/2019 38,89 40,09 38,00 39,65 +1,73% 5,37% 1.676.100
22/10/2019 37,12 39,25 36,88 38,98 +6,78% 6,38% 2.033.400
21/10/2019 36,37 36,89 35,03 36,50 +1,53% 5,11% 1.381.600